Jonathan Kearsey

423 total citations
7 papers, 345 citations indexed

About

Jonathan Kearsey is a scholar working on Molecular Biology, Organic Chemistry and Neurology. According to data from OpenAlex, Jonathan Kearsey has authored 7 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 1 paper in Organic Chemistry and 1 paper in Neurology. Recurrent topics in Jonathan Kearsey's work include RNA modifications and cancer (2 papers), RNA Interference and Gene Delivery (2 papers) and RNA and protein synthesis mechanisms (2 papers). Jonathan Kearsey is often cited by papers focused on RNA modifications and cancer (2 papers), RNA Interference and Gene Delivery (2 papers) and RNA and protein synthesis mechanisms (2 papers). Jonathan Kearsey collaborates with scholars based in France and Italy. Jonathan Kearsey's co-authors include Laurent Bracco, Denis Ravel, Françoise Cailler, Catherine de Coupade, Antonio Fittipaldi, Audrey Darmon, Ennio Tasciotti, Mauro Giacca, Jérôme Quinonero and Fabien Schweighoffer and has published in prestigious journals such as Biochemical Journal, Clinical Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Jonathan Kearsey

7 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan Kearsey France	7	280	49	49	36	33	7	345
Jakob Regberg Sweden	9	282 1.0×	42 0.9×	47 1.0×	65 1.8×	26 0.8×	11	348
Pascaline Lécorché France	10	214 0.8×	41 0.8×	45 0.9×	55 1.5×	26 0.8×	13	309
Yuran Xie United States	11	314 1.1×	33 0.7×	20 0.4×	63 1.8×	42 1.3×	16	406
Lorenzo Depau Italy	11	178 0.6×	41 0.8×	19 0.4×	48 1.3×	27 0.8×	15	257
Yunping Lu China	10	266 0.9×	107 2.2×	11 0.2×	20 0.6×	46 1.4×	22	406
John Astle United States	8	230 0.8×	88 1.8×	18 0.4×	9 0.3×	52 1.6×	17	350
Carmine Pasquale Cerrato Sweden	9	284 1.0×	12 0.2×	52 1.1×	36 1.0×	28 0.8×	15	329
Judith Mueller Germany	7	256 0.9×	28 0.6×	41 0.8×	15 0.4×	29 0.9×	10	330
Thomas R. Peavy United States	10	248 0.9×	22 0.4×	10 0.2×	50 1.4×	54 1.6×	14	485
Erzsébet Botos Hungary	8	223 0.8×	26 0.5×	9 0.2×	55 1.5×	24 0.7×	8	374

Countries citing papers authored by Jonathan Kearsey

Since Specialization

Citations

This map shows the geographic impact of Jonathan Kearsey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Kearsey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Kearsey more than expected).

Fields of papers citing papers by Jonathan Kearsey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Kearsey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Kearsey. The network helps show where Jonathan Kearsey may publish in the future.

Co-authorship network of co-authors of Jonathan Kearsey

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Kearsey. A scholar is included among the top collaborators of Jonathan Kearsey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Kearsey. Jonathan Kearsey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Ravel, Denis, Vincent Dubois, Jérôme Quinonero, et al.. (2008). Preclinical Toxicity, Toxicokinetics, and Antitumoral Efficacy Studies of DTS-201, a Tumor-Selective Peptidic Prodrug of Doxorubicin. Clinical Cancer Research. 14(4). 1258–1265. 24 indexed citations

2.

Nicolazzi, Céline, Jérôme Quinonero, Vincent Dubois, et al.. (2008). DTS-108, A Novel Peptidic Prodrug of SN38: In vivo Efficacy and Toxicokinetic Studies. Clinical Cancer Research. 14(7). 2145–2153. 58 indexed citations

3.

Quinonero, Jérôme, et al.. (2006). Improved Therapeutic Efficacy of Doxorubicin through Conjugation with a Novel Peptide Drug Delivery Technology (Vectocell). Journal of Medicinal Chemistry. 49(23). 6908–6916. 45 indexed citations

4.

Coupade, Catherine de, Antonio Fittipaldi, Ennio Tasciotti, et al.. (2005). Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules. Biochemical Journal. 390(2). 407–418. 116 indexed citations

5.

Kearsey, Jonathan, et al.. (2004). A novel four transmembrane spanning protein, CLP24. European Journal of Biochemistry. 271(13). 2584–2592. 23 indexed citations

6.

Bracco, Laurent & Jonathan Kearsey. (2003). The relevance of alternative RNA splicing to pharmacogenomics. Trends in biotechnology. 21(8). 346–353. 63 indexed citations

7.

Schweighoffer, Fabien, Annelies Resink, Brigitta M. N. Brinkman, et al.. (2000). Qualitative gene profiling: a novel tool in genomics and in pharmacogenomics that deciphers messenger RNA isoforms diversity. Pharmacogenomics. 1(2). 187–197. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact